[ Corporate » Management ]
Management
PolyMedix is in an advantageous position in that many of its senior management has previously worked together in successful biopharmaceutical endeavors. They form a cohesive, highly productive, and well-experienced team.
The management team members of PolyMedix include:
Nicholas Landekic 
is a Founder of PolyMedix, Inc. and has served as its President, Chief Executive Officer and
Director since inception in 2002. Mr. Landekic has more than 25 years of pharmaceutical industry experience. Prior to PolyMedix, he was President and Chief Executive Officer of Locus Discovery. Mr. Landekic has also held positions in Corporate/Business Development, Strategic Marketing, and Finance at Guilford Pharmaceuticals, Cephalon, Bristol-Myers Squibb and Johnson & Johnson Corporation (McNeil Pharmaceutical). In addition, he worked in the research laboratories at Mt. Sinai Medical Center. Mr. Landekic received an M.B.A. from the State University of New York at Albany, an M.A. in Biology from Indiana University and a B.S. in Biology from Marist College.
|
Bozena Korczak, Ph.D.
Ph.D., has served as Vice President, Drug Development of PolyMedix, Inc. since November 2007. Dr. Korczak has over 20 years of experience in discovery, pre clinical and clinical research at burgeoning biotechnology organizations. Prior to joining PolyMedix, Dr. Korczak was a Principal at PharmaReach, Ltd., a private drug development consulting company and Vice President of Research and Development of Cytochroma, Inc., a private biotechnology company. Dr. Korczak served in various positions of increasing responsibility at Glycodesign, Inc., Allelix Biopharmaceutical, Inc. and Mount Sinai Hospital. She is an author of thirty five peer review scientific papers and holds a Ph.D. in biochemistry from the Polish Academy of Science.
|
R. Eric McAllister, M.D., Ph.D., 
M.D., D.Phil, has served as Vice President, Clinical Development and Chief Medical Officer of PolyMedix, Inc. since November 2006. Dr. McAllister has over 25 years of industry and clinical trials experience. Prior to PolyMedix he served as Sr. Vice President of Clinical Development at CombinatoRx Inc. and Vice President, Clinical Research with Sicor Pharmaceuticals, Inc. Dr. McAllister has held various clinical development positions with TAP Pharmaceuticals, Inc., Cholestech Inc., Bristol Myers Squibb, Co., G.D. Searle and Company, and Syntex Pharmaceuticals Ltd. Dr. McAllister also spent seven years as a clinical investigator with MedStudies. He has worked on the development of such major pharmaceutical products as Lupron, Pravachol, Capoten, Kerlone, Cardene, Calan, Avandia, Actos, Teveten, and Atacand. Dr. McAllister received his M.D. from Dalhousie University, and D. Phil. degree from Oxford University, and was also a Rhodes Scholar. |
Richard W. Scott, Ph.D., 
has Ph.D., has served as Vice President, Research and a Founder of PolyMedix, Inc. since November 2002. Dr. Scott has approximately 30 years of biopharmaceutical industry experience. Prior to PolyMedix, he held positions of increasing responsibility at Cephalon, where he most recently served as Vice President of Biology. Dr. Scott also worked at the research laboratories of E.I. DuPont and Company, has authored more than 50 papers and book chapters, and is named on six patents. Dr. Scott holds a Ph.D. in Microbiology from the University of Pennsylvania and a B.S. in Biology with honors from Muhlenberg College.
|
|
Edward F. Smith,
has served as Vice President, Finance and Chief Financial Officer of PolyMedix, Inc. since January 2006. Mr. Smith has more than 15 years of combined biopharmaceutical industry and financial management experience. Prior to PolyMedix, he was Executive Director of Finance at InKine Pharmaceutical Company, Inc. (acquired by Salix Pharmaceuticals, Ltd. in 2005). Mr. Smith has held various positions of increasing responsibility in public accounting, most recently as a manager in the audit practice at Deloitte & Touche LLP. Mr. Smith is licensed as a Certified Public Accountant in Pennsylvania and holds a B.S. degree in Business Administration from the University of Hartford.
|
return to top ^ |
